Interestingly, the serum DKK1 level in the drug-resistant group was higher than that in the sensitive group, suggesting that DKK1 can be used as a marker for lung cancer screening, diagnosis, and chemotherapy efficacy evaluation [16]. Here, DKK1 is linked to lung carcinoma.